Literature DB >> 2091747

raf oncogenes in carcinogenesis.

S M Storm1, U Brennscheidt, G Sithanandam, U R Rapp.   

Abstract

There are three active raf genes in man and at least two in Xenopus and Drosophila. The mammalian c- and A-raf genes have 16 coding exons, which span 40 and 20 kb, respectively. B-raf is larger and extends over greater than 46 kb. Human c-raf-1 maps to chromosome 3p25 and A-raf-1 to Xp21. c-raf-1 RNA is present in many tissues, while A-raf and B-raf expression is restricted. A- and c-raf encode cytoplasmic ser/thr protein kinases of 68 and 74 kDa, which contain three conserved regions (CR). CR1 and 2 are in the amino terminal half, CR1 comprises the presumed ligand binding site, and CR3 represents the carboxy terminal kinase domain. All three genes can be artificially activated by deletions, provided CR3 is preserved. However, only c-raf-1 occurs naturally in truncated versions, such as v-raf and v-mil in the acutely transforming retroviruses 3611-MSV and MH2. raf transformation can also be affected by point mutation, suggesting that this mechanism may activate c-raf-1 as an oncogene in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091747

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  6 in total

1.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

Authors:  D Jacobs; D Glossip; H Xing; A J Muslin; K Kornfeld
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

3.  A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Carole Peyssonnaux; Joan Grindlay; Christian Kaiser; Helge Steen; Peter E Shaw; Harald Mischak; Alain Eychène; Walter Kolch
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts.

Authors:  Kathryn Mercer; Susan Giblett; Stuart Green; David Lloyd; Silvy DaRocha Dias; Mark Plumb; Richard Marais; Catrin Pritchard
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

5.  Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.

Authors:  F McPhillips; P Mullen; B P Monia; A A Ritchie; F A Dorr; J F Smyth; S P Langdon
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

6.  Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK.

Authors:  Fiona Hey; Catherine Andreadi; Catherine Noble; Bipin Patel; Hong Jin; Tamihiro Kamata; Kees Straatman; Jinli Luo; Kathryn Balmanno; David T W Jones; V Peter Collins; Simon J Cook; Christopher J Caunt; Catrin Pritchard
Journal:  Heliyon       Date:  2018-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.